Celemics, Inc. (331920.KQ) — Stock Score Summary

Celemics, Inc. (331920.KQ) has a MoatMap StockRank of 33/100 based on Quality (34/100), Value (37/100), and Momentum (49/100) factor scores. The current signal is SELL.

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna...

Key Financial Metrics

Price$9.87
Market Cap$110M
Price/Book5.32
Return on Equity-36.9%
Return on Invested Capital-17.4%
Debt/Equity21.94
Gross Margin42.9%
Operating Margin-154.4%
Revenue Growth-46.4%
Free Cash Flow$-940.71

Celemics, Inc. operates in the Medical Devices industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Celemics, Inc.’s (331920.KQ) StockRank?
MoatMap’s StockRank for Celemics, Inc. (331920.KQ) is 33/100, with a Sell signal. It is a composite of Quality (34), Value (37), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does Celemics, Inc. have an economic moat?
Celemics, Inc. (331920.KQ) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Celemics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Celemics, Inc. (331920.KQ) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Celemics, Inc. in?
Celemics, Inc. (331920.KQ) operates in the Healthcare sector, specifically the Medical Devices industry (South Korea).
Browse all ranked stocks331920.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock